Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors

Published:February 04, 2021DOI:https://doi.org/10.1016/j.pcd.2021.01.012

      Highlights

      • Retinopathy, microalbuminuria, and peripheral neuropathy coexist with the microvascular complications of type 2 diabetes.
      • Large cohort of 3090 patients in the real world setting has demonstrated the simultaneous association of diabetic retinopathy with nephropathy and neuropathy.
      • Our study highlights the need for monitoring for microalbuminuria that could be marker for the development of proliferative diabetic retinopathy.

      Abstract

      Background

      Diabetic Retinopathy (DR) is an important microvascular complication of diabetes that can lead to irreversible blindness. Microalbuminuria is strongly associated with diabetic retinopathy and can be used as a reliable marker of diabetic retinopathy.

      Aim

      To assess the association between DR, microalbuminuria, and other modifiable risk factors in patients with type 2 diabetes.

      Methodology

      3090 patients with T2DM visiting North Delhi Diabetes Centre, New Delhi between July 2016 to October 2019 were evaluated for the clinical and biochemical parameters that included urinary albumin, HbA1C, lipid profiles, serum creatinine estimation and underwent biothesiometry.

      Results

      3090 patients (1350 females and 1740 males), with mean age of 52.7 ± 9.2 years and diabetes duration ranging from 1 to 19 years (mean 9.4 ± 6), duration of less than 5 years, 6–10 years and more than 10 years in 52%, 26% and in 22%, respectively. Duration of diabetes was strong predictor of retinopathy (p = 0.001). The HbA1c and BMI in patients with DR was significantly higher than in those without DR. 18.2% patients were diagnosed to have retinopathy. Peripheral neuropathy was observed in 24.2% and was positively associated with DR (p = 0.002). 33.9% and 4.5% patients had microalbuminuria macroalbuminuria, respectively and 9.7% patients had creatinine >1.3 mg/dL. There was significant positive relationship between different grades of retinopathy and albuminuria.

      Conclusions

      Our study is a large real-world study that demonstrates that HbA1c, BMI, duration of diabetes, microalbuminuria and peripheral neuropathy are relatively, yet cohesively contributing factors towards varying grade of retinopathy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ramachandran A.
        • Snehalatha C.
        • Shetty A.S.
        • et al.
        Trends in prevalence of diabetes in Asian countries.
        World J. Diabetes. 2012; 3: 110-117
        • Cheung N.
        • Mitchell P.
        • Wong T.Y.
        Diabetic retinopathy.
        Lancet. 2010; 376: 124-136
        • Lee R.
        • Wong T.Y.
        • Sabanayagam C.
        Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
        Eye Vis. 2015; 2: 17
        • Yau J.W.
        • Rogers S.L.
        • Kawasaki R.
        • Lamoureux E.L.
        • Kowalski J.W.
        • Bek T.
        • et al.
        Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy.
        Diabetes Care. 2012; 35: 556-564
        • Comi-Diaz C.
        • Miralles-García J.M.
        • Cabrerizo L.
        • et al.
        Grado de control metabólicoen una población diabéticaatendidaenservicios de endocrinología [Cardiovascular risk factor control in a population with longstanding diabetes attending endocrinology departments].
        Endocrinol. Nutr. 2010; 57: 472-478
        • Jain A.
        • Sarraf D.
        • Fong D.
        Preventing diabetic retinopathy through control of systemic factors.
        Curr. Opin. Ophthalmol. 2003; 14: 389-394
      1. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2020.
        Diabetes Care. 2020; 43 (PMID: 31862745): S14-S31https://doi.org/10.2337/dc20-S002
        • Weber M.A.
        • Schiffrin E.L.
        • White W.B.
        • et al.
        Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension.
        J. Hypertens. 2014; 32: 3-15
        • Hackam D.G.
        • Quinn R.R.
        • Ravani P.
        • et al.
        The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
        Can. J. Cardiol. 2013; 29: 528-542
        • Parati G.
        • Stergiou G.S.
        • Asmar R.
        • et al.
        European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring.
        J. Hypertens. 2008; 26: 1505-1526
        • Ogihara T.
        • Kikuchi K.
        • Matsuoka H.
        • et al.
        The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009).
        Hypertens. Res. 2009; 32: 3-107
        • Eggertsen R.
        • Kalm H.
        • Blohme G.
        The values of screening for retinopathy and microalbuminuria in patients with type II diabetes in primary health care.
        Scand. J. Prim. Health Care. 1993; 11: 135-140
        • Liu D.P.
        • Molyneaux L.
        • Chua E.
        • Wang Y.Z.
        • Wu C.R.
        • Jing H.
        • Hu L.N.
        • Liu Y.J.
        • Xu Z.R.
        • Yue D.K.
        Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes.
        Diabetes Res. Clin. Pract. 2002; 56: 125-131
        • Wirta O.
        • Pasternack A.
        • Mustonen J.
        • Laippala P.
        • Lahde Y.
        Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus.
        Clin. Nephrol. 1999; 51: 329-334
        • Erasmus R.T.
        • Oyeyinka G.
        • Arije A.
        Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy.
        Postgrad. Med. J. 1992; 68: 638-642
        • Parving H.H.
        • Hommel E.
        • Mathiesen E.
        • Skott P.
        • Edsberg B.
        • Bahnsen M.
        • Lauritzen M.
        • Hougaard P.
        • Lauritzen E.
        Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.
        BMJ. 1988; 296: 156-160
        • Sobngwi E.
        • Mbanya J.
        • Moukouri E.N.
        • Ngu K.B.
        Microalbuminuria and retinopathy in a diabetic population of Cameroon.
        Diabetes Res. Clin. Pract. 1999; 44: 191-196
        • Lunetta M.
        • Infantone L.
        • Calogero A.
        • Infantone E.
        Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus.
        Diabetes Res. Clin. Pract. 1998; 40: 45-51
        • Cardoso C.R.L.
        • Salles G.C.
        • Leite N.C.
        • Salles G.F.
        Prognostic impact of short-term ambulatory blood pressure variability for microvascular and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
        J. Hypertens. 2020; (Epub ahead of print. PMID: 33239549)https://doi.org/10.1097/HJH.0000000000002710
        • Sztanek F.
        • Balogh B.
        • Molnár Á
        • Zöld E.
        • Tóth N.
        • Jakab A.Á
        • Paragh G.
        A diabetesesneuropathiaésegyébszövődményekelőfordulása a DebreceniEgyetemDiabetesesNeuropathiaCentrumában [Diabetic neuropathy and other diabetic complications at the Diabetic Neuropathy Center of the University of Debrecen].
        Orv. Hetil. 2020; 161 (Hungarian. PMID: 32653867): 1243-1251https://doi.org/10.1556/650.2020.31799
        • Hsieh Y.T.
        • Hsieh M.C.
        Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes - an 8-year prospective cohort study.
        Acta Ophthalmol. 2020; (Epub ahead of print. PMID: 32567151)https://doi.org/10.1111/aos.14487
        • Lv X.
        • Ran X.
        • Chen X.
        • Luo T.
        • Hu J.
        • Wang Y.
        • Liu Z.
        • Zhen Q.
        • Liu X.
        • Zheng L.
        • Tang Y.
        • Zhao Q.
        • Han S.
        • Zhou Y.
        • Luo W.
        • Yang L.
        • Li Q.
        • Wang Z.
        Early-onset type 2 diabetes: a high-risk factor for proliferative diabetic retinopathy (PDR) in patients with microalbuminuria.
        Medicine (Baltimore). 2020; 99 (PMID: 32384512; PMCID: PMC7220424)e20189https://doi.org/10.1097/MD.0000000000020189